Related Experiment Video
Updated: Jan 24, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Salidroside inhibits migration and invasion of poorly differentiated thyroid cancer cells
Hongxia Shang1, Shengnan Wang2, Jinming Yao1
1Division of Endocrinology, Department of Medicine, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Background:
No effective treatment is currently available for poorly differentiated thyroid cancer which is resistant to radioiodine, especially with migration and invasion. A great number of researches have revealed the anticancer effects of salidroside, but none have studied the effects of salidroside on thyroid cancer. This study aimed to investigate the effect of salidroside on migration and invasion of poorly differentiated thyroid cancer cells.
Methods:
The effects of salidroside on migration, invasion and apoptosis of poorly differentiated thyroid cancer WRO cells and normal thyroid follicular epithelial Nthy-ori 3-1 cells were measured by wound-healing assay, transwell migration/invasion assay and flow cytometry, respectively. The expression levels of MMP2 and MMP9 at RNA and protein levels in WRO cells were detected by qRT-PCR and western blot. The phosphorylation levels of Janus kinase 2 (JAK2), signal transducer and activator of transcription 3 (STAT3) and the apoptosis-related protein levels of Bax, cleaved caspase 3 and Bcl-2 were assessed by western blot.
Results:
Salidroside significantly suppressed migration/invasion and induced apoptosis in poorly differentiated thyroid cancer WRO cells. We further illustrated that salidroside significantly inhibited expressions of MMP2 and MMP9 at mRNA and protein levels and the phosphorylation activation of JAK2/STAT3 in WRO cells. In addition, salidroside increased expressions of pro-apoptotic factors (Bax and cleaved caspase 3) and decreased expression of anti-apoptotic factor (Bcl-2) significantly in WRO cells.
Conclusion:
The present study demonstrates that salidroside inhibits migration and invasion of WRO cells (a kind of poorly differentiated cancer cell line) significantly, which might be via suppressing JAK2-STAT3 signaling pathway.
Insights
Salidroside effectively inhibits the migration and invasion of poorly differentiated thyroid cancer cells. This natural compound also promotes cancer cell death by targeting the JAK2-STAT3 signaling pathway.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Poorly differentiated thyroid cancer lacks effective treatments, particularly when resistant to radioiodine and exhibiting metastasis.
- Salidroside demonstrates anticancer properties, yet its specific effects on thyroid cancer remain uninvestigated.
Purpose of the Study:
- To investigate the impact of salidroside on the migration and invasion capabilities of poorly differentiated thyroid cancer cells.
Main Methods:
- Utilized wound-healing and transwell assays to assess migration and invasion in WRO cells.
- Quantified MMP2 and MMP9 expression via qRT-PCR and Western blot.
- Analyzed JAK2/STAT3 phosphorylation and apoptosis-related proteins (Bax, cleaved caspase 3, Bcl-2) using Western blot.
Main Results:
- Salidroside significantly reduced migration and invasion in WRO cells while inducing apoptosis.
- Inhibited mRNA and protein expression of MMP2 and MMP9.
- Suppressed JAK2/STAT3 phosphorylation and modulated apoptosis-related protein levels.
Conclusions:
- Salidroside demonstrates significant potential in inhibiting thyroid cancer cell migration and invasion.
- The mechanism involves the suppression of the JAK2-STAT3 signaling pathway.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Feedback Inhibition
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Chemotaxis and Direction of Cell Migration

